The ESMO Colloquia are innovative sessions within the Congress programme that bring together top experts to discuss evolving areas of interest to the oncology community.
The Colloquia are organised by ESMO and supported by the industry in a unique collaboration making them the perfect complement to the scientific and education programme of the Congress. The industry has no influence on the content of the programme or speaker selection. All ESMO Colloquia are open to multi-sponsor support and interested sponsors can contact ESMO for more information on future programmes at programme@esmo.org
View the complete ESMO Breast Cancer 2022 programme online
Tuesday, 3 May 2022
Optimising risk prediction, management and compliance for patients with early HR+ HER2- breast cancer: The start of a journey
18:00 - 19:30 CEST (Central European Summer Time)
Munich Hall
View the ESMO colloquium details
This educational activity is provided by ESMO and supported by Eli Lilly
Learning Objectives
- To provide an update on risk prediction tools and algorithms for patients with early HR+ HER2- node-positive early breast cancer
- To provide an overview of adjuvant therapeutic pathways available in patients with early HR+ HER2- breast cancer
- To highlight state of the art toxicity and management strategies as a continuum of care for patients with HR+ HER2- breast cancer